Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDCC Regulatory News (DCC)

Share Price Information for DCC (DCC)

Share Price is delayed by 15 minutes
Get Live Data
6,025.00    0.00 (0.00%)
Bid:
4,300.00
Ask:
6,245.00
Spread: 1,945.00 (45.233%)
Market Cap: £5.15b
DCC Live PriceLast checked at - London Stock Exchange

Intraday DCC Share Chart

Board Changes

9 Nov 2021 07:00

RNS Number : 7218R
DCC PLC
09 November 2021
 

 

9 November 2021

Board Changes

 

Appointment of New Non-Executive Director

DCC plc, the leading international sales, marketing and support services group, announces the appointment of Mr. Alan Ralph as a non-executive Director and member of the Audit Committee with effect from 8 November 2021.

Mr. Ralph is a very experienced business and finance leader having spent almost 20 years with UDG Healthcare plc (formerly United Drug plc). Mr. Ralph spent ten years leading UDG's largest business unit before supporting its strategic transformation as Chief Financial Officer for five years. Mr. Ralph is a Chartered Accountant.

There are no details to be disclosed under Listing Rule 9.6.13 in respect of Mr. Ralph.

Appointment of Workforce Engagement Director

Mr. Mark Ryan, who has been a non-executive Director since November 2017, has been appointed as the designated Director for engagement with the workforce, succeeding Mr. Cormac McCarthy who passed away in July 2021. Mr. Ryan has also been appointed as a member of the Governance and Sustainability Committee. Both appointments take effect from 8 November 2021.

Mark Breuer, Chairman of DCC plc, said:

"I warmly welcome Alan Ralph to the Board. His financial expertise, business leadership experience and knowledge of the healthcare sector will enhance the Board's knowledge in several key areas."

"I am also very pleased that Mark Ryan will take on the important role of workforce engagement Director. Mark has been a valued member of the Board since 2017 and will bring his knowledge of DCC and extensive business experience to the position."

Contact information 

Investor enquiries:

Darragh Byrne, Company Secretary

Rossa White, Head of Group Investor Relations

Tel: +353 1 2799 400

Email: investorrelations@dcc.ie

 

 

Media enquiries:

Powerscourt (Eavan Gannon/Victoria Palmer Moore)

Tel: +44 20 7250 1446

Email: DCC@powerscourt-group.com

 

 

DCC website:

www.dcc.ie

 

 

About DCC plc

DCC is a leading international sales, marketing and support services group with a clear focus on performance and growth. It operates through four divisions: LPG, Retail & Oil, Healthcare and Technology. DCC plc is listed on the London Stock Exchange and is a constituent of the FTSE 100. In its financial year ended 31 March 2021, DCC generated revenue of £13.4 billion and operating profit of £530.2 million.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABPBLTMTTMBMB
Date   Source Headline
5th Sep 20257:00 amRNSTransaction in Own Shares
4th Sep 20257:00 amRNSTransaction in Own Shares
3rd Sep 20257:00 amRNSTransaction in Own Shares
2nd Sep 20257:00 amRNSTransaction in Own Shares
1st Sep 202510:56 amRNSTotal Voting Rights
1st Sep 20257:00 amRNSTransaction in Own Shares
29th Aug 20257:00 amRNSTransaction in Own Shares
28th Aug 20257:00 amRNSTransaction in Own Shares
27th Aug 20257:00 amRNSTransaction in Own Shares
26th Aug 20257:00 amRNSTransaction in Own Shares
22nd Aug 20257:00 amRNSTransaction in Own Shares
21st Aug 20257:00 amRNSTransaction in Own Shares
20th Aug 20256:11 pmRNSHigh Court Approval of Reduction of Capital
20th Aug 20257:00 amRNSTransaction in Own Shares
19th Aug 20257:00 amRNSTransaction in Own Shares
18th Aug 20257:00 amRNSTransaction in Own Shares
15th Aug 20257:00 amRNSTransaction in Own Shares
14th Aug 20257:00 amRNSTransaction in Own Shares
13th Aug 20257:00 amRNSTransaction in Own Shares
12th Aug 20257:00 amRNSTransaction in Own Shares
11th Aug 20257:00 amRNSTransaction in Own Shares
8th Aug 20257:00 amRNSTransaction in Own Shares
7th Aug 20257:00 amRNSTransaction in Own Shares
6th Aug 20257:00 amRNSTransaction in Own Shares
5th Aug 20257:00 amRNSTransaction in Own Shares
4th Aug 20257:00 amRNSTransaction in Own Shares
1st Aug 20257:00 amRNSTransaction in Own Shares
31st Jul 20257:00 amRNSTransaction in Own Shares
30th Jul 20257:00 amRNSTransaction in Own Shares
29th Jul 20257:00 amRNSTransaction in Own Shares
28th Jul 20257:00 amRNSTransaction in Own Shares
25th Jul 20257:00 amRNSTransaction in Own Shares
24th Jul 20257:00 amRNSTransaction in Own Shares
23rd Jul 20257:00 amRNSTransaction in Own Shares
22nd Jul 20257:00 amRNSTransaction in Own Shares
21st Jul 20257:00 amRNSTransaction in Own Shares
18th Jul 20257:00 amRNSTransaction in Own Shares
17th Jul 20257:00 amRNSTransaction in Own Shares
16th Jul 20257:00 amRNSTransaction in Own Shares
15th Jul 20257:00 amRNSTransaction in Own Shares
14th Jul 20257:00 amRNSDivestment of Info Tech business
14th Jul 20257:00 amRNSTransaction in Own Shares
11th Jul 20257:00 amRNSTransaction in Own Shares
10th Jul 20255:42 pmRNSResult of AGM
10th Jul 20257:00 amRNSAGM Trading Statement
10th Jul 20257:00 amRNSTransaction in Own Shares
9th Jul 20257:00 amRNSTransaction in Own Shares
8th Jul 20257:00 amRNSTransaction in Own Shares
7th Jul 20257:00 amRNSTransaction in Own Shares
4th Jul 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.